Rupa Briggs is a partner in the Firm's Capital Markets Practice in New York. Rupa represents issuers and financial institutions in debt and equity capital markets transactions, with a particular focus on initial public offerings, registered equity offerings and public mergers and acquisitions.
Rupa also advises public companies on a broad range of disclosure, corporate governance and general corporate matters.
Rupa has experience with transactions in a wide range of industries, including technology, healthcare and consumer products.
Represented Kornit Digital Ltd. on its follow-on offering of ordinary shares.
Represented Hertz Global Holdings, Inc., as issuer, in its over-subscribed rights offering at the subscription price of US$12.95. The Company issued an aggregate of 57,915,055 new shares of common stock for total gross proceeds of approximately US$750 million.
Represented Kornit Digital Ltd. on its secondary offering of ordinary shares by Fortissimo Capital Fund II (Israel) L.P.
Represented Altice USA in its initial public offering and in its subsequent spin-off from its controlling stockholder, Altice Europe.*
Represented BofA Merrill Lynch and Cowen, as representatives of the underwriters, in the initial public offering of Y-mAbs Therapeutics.*
Represented BofA Merrill Lynch and Goldman Sachs, as representatives of the underwriters, in the initial public offering of Inspire Medical Systems.*
Represented BofA Merrill Lynch, Citigroup and Morgan Stanley, as representatives of the underwriters, in the initial public offering of Valvoline.*
Represented CVS Health Corporation in its $40 billion debt offering to finance the acquisition of Aetna Inc.*
* Matters prior to joining White & Case
"The Corporate Balancing Act: How Can Directors Manage Conflicting Pressures?" Salzburg Global Seminar Session Report 567, February 14, 2017.